EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SHL Telemedicine's Enterprise Value is CHF30.16 Mil.
SHL Telemedicine's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-3.94 Mil. Therefore, SHL Telemedicine's EV-to-FCF for today is -7.65.
The historical rank and industry rank for SHL Telemedicine's EV-to-FCF or its related term are showing as below:
XSWX:SHLTN'
s EV-to-FCF Range Over the Past 10 Years
Min: -96.61 Med: -3.51 Max: 82.22
Current: -7.65
During the past 13 years, the highest EV-to-FCF of SHL Telemedicine was 82.22. The lowest was -96.61. And the median was -3.51.
XSWX:SHLTN's EV-to-FCF is ranked worse than 100% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 17.97
vs XSWX:SHLTN: -7.65
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SHL Telemedicine's PE Ratio (TTM) for today is calculated as:
SHL Telemedicine's share price for today is CHF1.08.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-0.576.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SHL Telemedicine EV-to-FCF Related Terms
SHL Telemedicine EV-to-FCF Historical Data
* Premium members only.
The historical data trend for SHL Telemedicine's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SHLTN vs VEEV, BTSG, TEM: EV-to-FCF Comparison
For the Health Information Services subindustry, SHL Telemedicine's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's EV-to-FCF falls into.
SHL Telemedicine's current Enterprise Value is CHF30.16 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-3.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine (XSWX:SHLTN) has a EV-to-FCF of -7.65 as of Jul. 11, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SHL Telemedicine and its competitors. According to the industry distribution chart, SHL Telemedicine ranks #999999 out of 405 companies in the Healthcare Providers & Services industry.
Is SHL Telemedicine's EV-to-FCF too high?
SHL Telemedicine's current EV-to-FCF is -7.65. Based on the distribution chart, SHL Telemedicine ranks #999999 out of 405 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, SHL Telemedicine has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #999999 out of 405 companies for EV-to-FCF. This places SHL Telemedicine in the lower half of its industry. The industry median EV-to-FCF is 17.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.97, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SHL Telemedicine and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current EV-to-FCF is -7.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
Based on GuruFocus' analysis, SHL Telemedicine (XSWX:SHLTN) is currently considered Possible Value Trap. The stock's GF Value™ is CHF2.62, compared to a current price of CHF1.08 — trading 58.8% below its estimated fair value. The current EV-to-FCF is -7.65. SHL Telemedicine's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For SHL Telemedicine (XSWX:SHLTN), the current EV-to-FCF is -7.65 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SHL Telemedicine (XSWX:SHLTN) Overvalued in 2026?
Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued.
The current stock price of CHF1.08 is trading 58.8% below its estimated GF Value™ of CHF2.62.
GuruFocus considers SHL Telemedicine to be Possible Value Trap.
Key valuation signals for XSWX:SHLTN:
EV-to-FCF: -7.65
GF Value™: CHF2.62 vs. price of CHF1.08 (58.8% below fair value)
No single metric tells the full story. See the XSWX:SHLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
52GF Score
Get the complete analysis for XSWX:SHLTN
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SHLTN has been successfully added to your 
